Back to mobile site

Sanofi (SNY) and Alnylam (ALNY) APOLLO Phase 3 Study of Patisiran in hATTR Meets Primary, Secondary Endpoints

September 20, 2017 7:01 AM EDT Send to a Friend
Sanofi Genzyme, the specialty care global business unit of Sanofi (NYSE: SNY), and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login